✨ Free AI Report
SD Biosensor, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research SD Biosensor, Inc.
Company Research

SD Biosensor, Inc.: Business Overview, Financials & Competitive Analysis

SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnos...

Analyst-debate audio for SD Biosensor, Inc.

AskCyborg analysts argue the bull and bear cases for SD Biosensor, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Strong emerging-market positioned IVD player with diversified platform technology and expanding global footprint, benefiting from...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest SD Biosensor, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

SD Biosensor, Inc. Overview

Pro stress-test →

SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnostic platforms spanning rapid immunochemical tests, molecular diagnostics, fluorescence immunoassay systems, and blood glucose monitoring devices for healthcare providers and patients globally.

Strategic Profile

Pro stress-test →

SD Biosensor operates a diversified product portfolio including STANDARD Q (rapid diagnostics), STANDARD F (laboratory FIA systems), STANDARD M (point-of-care molecular diagnostics), and blood glucose monitoring solutions. The company maintains a strong international presence with subsidiaries across the USA, Brazil, Germany, Italy, Spain, India, and Indonesia, positioning itself as a leading global IVD provider serving both developed and low-to-middle income countries.

Competitive Landscape

Pro stress-test →

SD Biosensor competes in the global IVD market against multinational giants (Abbott, Roche, Siemens, Bio-Rad) and regional players. The company differentiates through point-of-care solutions, emerging market focus, and platform technology. Competitive advantages include rapid product development, global distribution network, and lower-cost solutions suited for resource-constrained settings.

Industry Context

SD Biosensor, Inc. operates in In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare.

Key facts

Founded: 2010 · Headquarters: Suwon, South Korea · Employees: 649 · Revenue: $494M · Market cap: $848M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on SD Biosensor, Inc..

  • Diversified diagnostic platform spanning rapid tests, FIA systems, molecular diagnostics, and blood glucose monitoring creates multiple revenue streams
  • Global expansion through subsidiaries in 9+ countries positions company for emerging market growth where point-of-care diagnostics are increasingly critical
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026$21 Million investment announced for molecular diagnostic testing expansion in low-to-middle income countries
  • 2025SD Biosensor released 2025 Sustainability Management Report highlighting sustainable growth initiatives
  • +1 moreTrack every material event for SD Biosensor, Inc. as it happens. Explore monitoring →
Get alerted when SD Biosensor, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Rapid Diagnostics PortfolioGlobal leader in point-of-care diagnostics→Molecular & Lab DiagnosticsLargest global IVD company with integrated laboratory systems→Point-of-Care SystemsDiversified diagnostics from POC to laboratory automation→Blood Glucose MonitoringDominant players in diabetes management diagnostics→

Compare SD Biosensor, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

SD Biosensor, Inc. operates in In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare research →
NEW · MCP server

Ask your AI assistant about SD Biosensor, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare SD Biosensor, Inc. and its top competitor on Cyborg Score”
“What did SD Biosensor, Inc. do this quarter?”
“Is SD Biosensor, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does SD Biosensor, Inc. do?+
SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnos...
What is SD Biosensor, Inc.'s Cyborg Score?+
SD Biosensor, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are SD Biosensor, Inc.'s main competitors?+
Named competitors include Rapid Diagnostics Portfolio, Molecular & Lab Diagnostics, Point-of-Care Systems, Blood Glucose Monitoring. The full competitive landscape is in the AskCyborg report.
How can I get the full SD Biosensor, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the SD Biosensor, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track SD Biosensor, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.